GRM3

glutamate metabotropic receptor 3, the group of Glutamate metabotropic receptors

Basic information

Region (hg38): 7:86643909-86864879

Links

ENSG00000198822NCBI:2913OMIM:601115HGNC:4595Uniprot:Q14832AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GRM3 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GRM3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
6
clinvar
2
clinvar
8
missense
19
clinvar
2
clinvar
21
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 19 6 4

Variants in GRM3

This is a list of pathogenic ClinVar variants found in the GRM3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-86765277-G-A Benign (Dec 31, 2019)768176
7-86765334-C-A not specified Uncertain significance (Aug 08, 2023)2616923
7-86765537-C-T not specified Uncertain significance (Dec 20, 2023)3102653
7-86786404-C-G not specified Uncertain significance (Nov 21, 2023)3102654
7-86786408-C-T not specified Uncertain significance (Feb 22, 2023)2468929
7-86786442-C-A not specified Uncertain significance (May 14, 2024)3282870
7-86786491-A-C EBV-positive nodal T- and NK-cell lymphoma Likely benign (-)2681307
7-86786530-G-A Likely benign (Feb 09, 2018)781037
7-86786583-T-C not specified Uncertain significance (Dec 04, 2023)3102655
7-86786591-C-T not specified Uncertain significance (Jan 30, 2024)3102656
7-86786608-G-C Likely benign (Mar 29, 2018)737837
7-86786679-C-G not specified Uncertain significance (Jan 03, 2024)3102657
7-86786945-G-A not specified Uncertain significance (Apr 04, 2023)2532701
7-86787053-G-A not specified Uncertain significance (Nov 22, 2023)3102649
7-86838938-G-A Benign (May 01, 2022)2657657
7-86838980-C-A not specified Uncertain significance (Aug 26, 2022)2212176
7-86838987-G-A Likely benign (Apr 11, 2018)749336
7-86838998-A-C not specified Uncertain significance (Feb 06, 2024)3102650
7-86839013-C-T not specified Uncertain significance (Jun 24, 2022)2296417
7-86839280-T-C not specified Uncertain significance (May 09, 2024)3282869
7-86839354-C-T not specified Uncertain significance (Mar 18, 2024)3282868
7-86839392-C-T Likely benign (Aug 14, 2018)750890
7-86839402-T-A not specified Uncertain significance (Aug 17, 2021)2231605
7-86839434-C-T Likely benign (May 29, 2018)747080
7-86839525-G-A not specified Uncertain significance (Dec 28, 2022)2403877

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GRM3protein_codingprotein_codingENST00000361669 5220971
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.7850.2151257320161257480.0000636
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.203235300.6090.00003235782
Missense in Polyphen109244.470.445862681
Synonymous0.7842052200.9330.00001471738
Loss of Function4.21631.50.1910.00000169366

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002600.000260
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00004420.0000439
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.0001650.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling inhibits adenylate cyclase activity. {ECO:0000269|PubMed:8840013}.;
Pathway
Glutamatergic synapse - Homo sapiens (human);Phospholipase D signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Cocaine addiction - Homo sapiens (human);GPCRs, Class C Metabotropic glutamate, pheromone;Signaling by GPCR;Signal Transduction;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;G alpha (i) signalling events;GPCR signaling-G alpha i;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.255

Intolerance Scores

loftool
0.0728
rvis_EVS
-1.29
rvis_percentile_EVS
5.08

Haploinsufficiency Scores

pHI
0.494
hipred
Y
hipred_score
0.800
ghis
0.603

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.674

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Grm3
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype;

Gene ontology

Biological process
G protein-coupled receptor signaling pathway;negative regulation of adenylate cyclase activity;adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway;G protein-coupled glutamate receptor signaling pathway;chemical synaptic transmission;regulation of synaptic transmission, glutamatergic
Cellular component
plasma membrane;integral component of plasma membrane;postsynaptic density;axon;dendritic spine;glutamatergic synapse;integral component of postsynaptic membrane;integral component of presynaptic membrane
Molecular function
group II metabotropic glutamate receptor activity;G protein-coupled receptor activity;calcium channel regulator activity;glutamate receptor activity